Neuronetics Inc [STIM] stock is trading at $1.49, down -0.33%. An important factor to consider is whether the stock is rising or falling in short-term value. The STIM shares have lost -31.02% over the last week, with a monthly amount drifted -48.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Neuronetics Inc [NASDAQ: STIM] stock has seen the most recent analyst activity on August 13, 2024, when William Blair downgraded its rating to a Mkt Perform. Previously, William Blair downgraded its rating to Mkt Perform on October 13, 2021. On October 13, 2021, downgrade downgraded it’s rating to Neutral. William Blair upgraded its rating to a Outperform. BTIG Research initiated its recommendation with a Buy and recommended $11 as its price target on February 06, 2020.
Neuronetics Inc [STIM] stock has fluctuated between $0.68 and $5.92 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Neuronetics Inc [NASDAQ: STIM] shares were valued at $1.49 at the most recent close of the market. An investor can expect a potential return of 436.91% based on the average STIM price forecast.
Analyzing the STIM fundamentals
Neuronetics Inc [NASDAQ:STIM] reported sales of 129.87M for the trailing twelve months, which represents a growth of 101.28%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -0.29%, Pretax Profit Margin comes in at -0.34%, and Net Profit Margin reading is -0.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -1.5 and Total Capital is -0.32. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3450 points at the first support level, and at 1.2000 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5800, and for the 2nd resistance point, it is at 1.6700.
Ratios To Look Out For
For context, Neuronetics Inc’s Current Ratio is 2.24. On the other hand, the Quick Ratio is 2.09, and the Cash Ratio is 1.19. Considering the valuation of this stock, the price to sales ratio is 0.79, the price to book ratio is 3.73.
Transactions by insiders
Recent insider trading involved Madryn Asset Management, LP, 10% Owner, that happened on Aug 08 ’25 when 3.5 million shares were sold. 10% Owner, MADRYN HEALTH PRTS II (CAY MAS completed a deal on Aug 08 ’25 to buy 2.93 million shares. Meanwhile, 10% Owner MADRYN HEALTH PARTNERS II, LP bought 0.19 million shares on Aug 08 ’25.
